James A. L. Brown

3.2k total citations
51 papers, 2.4k citations indexed

About

James A. L. Brown is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, James A. L. Brown has authored 51 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 21 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in James A. L. Brown's work include Epigenetics and DNA Methylation (9 papers), DNA Repair Mechanisms (8 papers) and MicroRNA in disease regulation (8 papers). James A. L. Brown is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), DNA Repair Mechanisms (8 papers) and MicroRNA in disease regulation (8 papers). James A. L. Brown collaborates with scholars based in Ireland, United States and United Kingdom. James A. L. Brown's co-authors include Michael J. Kerin, Andrew McGuire, J. Martin Brown, Ray McLaughlin, Carmel Malone, Emer Bourke, Changchun Deng, Peter McAnena, Geoffrey W. Birrell and Angela Chu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

James A. L. Brown

51 papers receiving 2.3k citations

Peers

Countries citing papers authored by James A. L. Brown

Since Specialization

Citations

This map shows the geographic impact of James A. L. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. L. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. L. Brown more than expected).

Fields of papers citing papers by James A. L. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. L. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. L. Brown. The network helps show where James A. L. Brown may publish in the future.

Co-authorship network of co-authors of James A. L. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of James A. L. Brown. A scholar is included among the top collaborators of James A. L. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. L. Brown. James A. L. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hypoxia-Responsive Polymersomes for Stemness Reduction in Patient-Derived Solid Tumor Spheroids 2025 ·ACS Applied Bio Materials ·(unknown), Narendra Kale, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Daniel Tuvin, Sajitha Kalathingal, Jagadish Loganathan, Yongki Choi, Venkatachalem Sathish, James A. L. Brown, Sanku Mallik	2
2	Evaluating the Cellular Roles of the Lysine Acetyltransferase Tip60 in Cancer: A Multi-Action Molecular Target for Precision Oncology 2024 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), James A. L. Brown	3
3	Centrosome amplification promotes cell invasion via cell–cell contact disruption and Rap-1 activation 2023 ·Journal of Cell Science ·(unknown), (unknown), Mark Webber, (unknown), Sri HariKrishna Vellanki, Kerry Thompson, Peter Dockery, Hanne Jahns, James A. L. Brown, Ann M. Hopkins, Emer Bourke	3
4	Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer 2019 ·BMC Cancer ·Peter McAnena, Kahraman Tanrıverdi, Catherine Curran, Katie Gilligan, Jane E. Freedman, James A. L. Brown, Michael J. Kerin	66
5	Recent Advances in Understanding FOXN3 in Breast Cancer, and Other Malignancies 2019 ·Frontiers in Oncology ·Xiangyi Kong, Jie Zhai, (unknown), Yan Song, Jing Wang, Xiaofeng Bai, James A. L. Brown, Yi Fang	26
6	Producing scientific posters, using online scientific resources, improves applied scientific skills in undergraduates 2018 ·Journal of Biological Education ·James A. L. Brown	6
7	Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab 2017 ·Breast Cancer Research and Treatment ·(unknown), (unknown), Emma Holian, Catherine Curran, Carmel Malone, (unknown), Aoïfe Lowery, James A. L. Brown, Michael J. Kerin	8
8	Practical Bioinformatics Analysis of MiRNA Data Using Online Tools 2016 ·Methods in molecular biology ·James A. L. Brown, Emer Bourke	4
9	Exploring circulating micro‐RNA in the neoadjuvant treatment of breast cancer 2016 ·International Journal of Cancer ·(unknown), Karl Sweeney, James A. L. Brown, Michael J. Kerin	33
10	ROCK activity and the Gβγ complex mediate chemotactic migration of mouse bone marrow-derived stromal cells 2015 ·Stem Cell Research & Therapy ·(unknown), James A. L. Brown, Emer Bourke, Áine M. Prendergast, (unknown), Zhonglin Liu, Peter Owens, Georgina Shaw, Walter Kölch, Timothy O’Brien, Frank Barry	11
11	Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring 2015 ·Cancer and Metastasis Reviews ·Andrew McGuire, James A. L. Brown, Michael J. Kerin	260
12	Primary cilium-associated genes mediate bone marrow stromal cell response to hypoxia 2014 ·Stem Cell Research ·James A. L. Brown, (unknown), Peter Owens, Aline M. Morrison, Frank Barry	15
13	A Novel Role for hSMG-1 in Stress Granule Formation 2011 ·Molecular and Cellular Biology ·James A. L. Brown, Tara L. Roberts, Renée S. Richards, Rick Woods, Geoffrey W. Birrell, Yi Chieh Lim, Shigeo Ohno, Akio Yamashita, Robert T. Abraham, Nuri Gueven, Martin F. Lavin	39
14	Detection of HER2 amplification in circulating free DNA in patients with breast cancer 2011 ·British Journal of Cancer ·Karen Page, Natasha Hava, Brian Ward, James A. L. Brown, David S. Guttery, (unknown), Kevin Blighe, Ashutosh Sharma, R A Walker, R. Charles Coombes, Jacqui Shaw	68
15	Circulating Tumor Cells and Plasma DNA Analysis in Patients with Indeterminate Early or Metastatic Breast Cancer 2011 ·Biomarkers in Medicine ·Jacqui Shaw, James A. L. Brown, R. Charles Coombes, Jimmy Jacob, Rachel Payne, Belinda Lee, Karen Page, Natasha Hava, Justin Stebbing	27
16	Genomic analysis of circulating cell-free DNA infers breast cancer dormancy 2011 ·Genome Research ·Jacqui Shaw, Karen Page, Kevin Blighe, Natasha Hava, David S. Guttery, (unknown), James A. L. Brown, (unknown), Justin Stebbing, Rachel Payne, Carlo Palmieri, Susan Cleator, Rosemary A. Walker, R. Charles Coombes	140
17	The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy 2011 ·British Journal of Cancer ·Rachel Payne, Natasha Hava, Karen Page, Kevin Blighe, Brian Ward, Martin J. Slade, James A. L. Brown, David S. Guttery, (unknown), Justin Stebbing, Jake Jacob, Ernesto Yagüe, Jacqui Shaw, R. Charles Coombes	13
18	MCPH1/BRIT1 limits ionizing radiation-induced centrosome amplification 2010 ·Oncogene ·James A. L. Brown, Emer Bourke, Catherine H. Liptrot, Peter Dockery, Ciaran G. Morrison	28
19	DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2 2009 ·Oncogene ·Emer Bourke, James A. L. Brown, Shunichi Takeda, Helfrid Hochegger, Ciaran G. Morrison	37
20	Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents 2002 ·Proceedings of the National Academy of Sciences ·Geoffrey W. Birrell, James A. L. Brown, (unknown), Guri Giaever, Angela Chu, Ronald W. Davis, J. Martin Brown	205

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact